大体积前列腺增生:双极等离子剜除术与开放前列腺切除术的单中心3年比较
单中心队列研究纳入240例大体积(>80 g)良性前列腺增生患者,其中111例(46%)行开放前列腺切除术(OP),129例(54%)行双极等离子剜除术(B-TUEP)。两组3年疗效持久,再干预率OP组7.5%、B-TUEP组5%;B-TUEP高危并发症更少。
要点
- 大体积前列腺(>80 g)中B-TUEP与OP的3年疗效均持久。
- 再干预率OP组7.5%,B-TUEP组5%。
- B-TUEP较OP的高级别并发症更少。
核心结论
- 单中心研究显示B-TUEP是大体积前列腺增生OP的有效替代方案,3年结局优良。
研究设计与样本
- 单中心队列研究,纳入2012年5月至2013年12月因良性前列腺增大致下尿路症状行B-TUEP或OP的患者。
- 共240例,OP组111例(46%),B-TUEP组129例(54%)。
- 随访节点为0、1、3、6、12、24、36个月,收集临床病史、体格检查、排尿症状、勃起功能、尿流率和前列腺体积,记录早期与长期并发症。
主要发现
- 两组3年疗效均持久,再干预率OP组7.5%、B-TUEP组5%。
- B-TUEP较OP的高级别并发症更少。
临床怎么用
- 对大体积(>80 g)良性前列腺增生患者,B-TUEP可作为OP的替代术式,需关注其高级别并发症更少的特点。
局限性
- 单中心研究,作者建议需进一步多中心研究确认结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKROUND: Aim of our study is to compare the surgery outcomes and safety of button bipolar enucleation of the prostate vs. open prostatectomy in patients with large prostates (> 80 g) in a single-centre cohort study. MATERIALS AND METHODS: All patients with lower urinary tract symptoms due to benign prostatic enlargement undergoing button bipolar enucleation of the prostate (B-TUEP) or open prostatectomy (OP) between May 2012 and December 2013 were enroled in our study. Data on clinical history, physical examination, urinary symptoms, erectile function, uroflowmetry and prostate volume were collected at 0, 1, 3, 6, 12, 24 and 36 months. Early and long-term complications were recorded. RESULTS: Overall, 240 patients were enroled. Out of them 111 patients (46%) performed an OP and 129 patients (54%) performed a B-TUEP. In terms of efficacy, both procedures showed durable results at three years with a reintervention rate of 7.5% in the OP group and 5% in the B-TUEP group. In terms of safety, B-TUEP presented less high-grade complications when compared with OP. CONCLUSIONS: In our single-centre study, B-TUEP represents a valid alternative to OP with excellent outcomes at three years. Further multicentre studies should confirm our results.
引用
- Giulianelli R, Gentile BC, Mirabile G, et al. Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison. Prostate Cancer Prostatic Dis. 2018. PMID: 30131603. doi:10.1038/s41391-018-0080-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。